Prostatic Hyperplasia: Clinical Trials

2 trials for Prostatic Hyperplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Terminated 2

Follow Prostatic Hyperplasia: new trials by email Literature Review of Prostatic Hyperplasia trials Research Report on Prostatic Hyperplasia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
Dutasteride/Tamsulosin - Prostatic Hyperplasia
Phase 4TerminatedGlaxoSmithKline592012-06-292018-08-20
Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter
Dutasteride - Benign Prostatic Hyperplasia
Phase 4TerminatedGlaxoSmithKline2762007-03-012007-11-27

Broader conditions

Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Male Urogenital Diseases (2)  ·  Prostatic Diseases (2)  ·  Urogenital Diseases (2)

Interventions

Dutasteride (2)  ·  Tamsulosin (1)

Sponsors

GlaxoSmithKline (2)

Countries

United Kingdom (1)  ·  Vietnam (1)